Company news
Lexicon Pharmaceuticals, Inc. news in 2021
Lexicon Pharmaceuticals, Inc.'s news releases, calls and decks from 2021, newest first.
Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults With Type 2 Diabetes
December 29, 2021
Lexicon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical Update
November 2, 2021
Craig Granowitz, M.D., Ph.D. Joins Lexicon as Senior Vice President and Chief Medical Officer
July 29, 2021
Lexicon Pharmaceuticals to Host Second Quarter 2021 Financial Results Conference Call and Webcast on July 30, 2021
July 27, 2021
Lexicon Pharmaceuticals Announces Symposium at the American Diabetes Association 81st Scientific Sessions
June 24, 2021
Lexicon Pharmaceuticals Announces Two Presentations at the American College of Cardiology’s 70th Annual Scientific Session
May 12, 2021
Lexicon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical Update
May 5, 2021
Lexicon Pharmaceuticals to Host First Quarter 2021 Financial Results Conference Call and Webcast on May 6, 2021
April 28, 2021
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Clinical Update
March 9, 2021
Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2020 Financial Results Conference Call and Webcast on March 10, 2021
March 3, 2021
Lexicon Pharmaceuticals Provides Regulatory Update on Sotagliflozin in Heart Failure
January 13, 2021
Calls in 2021
- Lexicon Pharmaceuticals (NASDAQ:LXRX) Q3 2021 Earnings Call
Nov 3, 2021
Transcript - Lexicon Pharmaceuticals (NASDAQ:LXRX) Q2 2021 Earnings Call
Jul 30, 2021
Transcript - Lexicon Pharmaceuticals (NASDAQ:LXRX) Q1 2021 Earnings Call
May 6, 2021
Transcript - Lexicon Pharmaceuticals (NASDAQ:LXRX) Q4 2020 Earnings Call
Mar 10, 2021
Transcript